Seer (SEER) Change in Accured Expenses (2020 - 2026)
Seer (SEER) posted quarterly Change in Accured Expenses of -$2.4 million for Q1 2026, down 16.34% year-over-year from -$2.8 million in Q1 2025, and down 731.47% quarter-over-quarter from -$286000.0 in Q4 2025.
Seer (SEER) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Seer's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 16.34% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$854000.0 (up 46.56% YoY), while the FY2025 annual figure was -$520000.0, up 63.59% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$2.4 million, down from -$286000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.4 million in Q2 2024, with the low at -$3.1 million in Q4 2024.
- The 5-year median for Change in Accured Expenses is $161000.0 (2025), against an average of -$172117.6.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses jumped 1922.81% in 2023, then plunged 1081.47% in 2024.
- Seer's Change in Accured Expenses stood at $615000.0 in 2022, then slumped by 49.11% to $313000.0 in 2023, then slumped by 1081.47% to -$3.1 million in 2024, then surged by 90.69% to -$286000.0 in 2025, then plunged by 731.47% to -$2.4 million in 2026.
- Business Quant data shows SEER's Change in Accured Expenses at -$2.4 million in Q1 2026, -$286000.0 in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241,000.00 |
| Jun 30, 2026 | 241,000.00 |
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -286,000.00 |
| Dec 31, 2025 | -286,000.00 |
| Sep 30, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Mar 31, 2024 | -1.87 Mn |